Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,493 stories indexed, page 142 of 159

🇩🇪Researchcharite.de

Charité: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Berlin Institute of Health: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Neues aus der Charité: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source
🇩🇪Researchcharite.de

Navi App: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source
🇩🇪Researchcharite.de

Campus Charité Mitte: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source
🇩🇪Researchcharite.de

Campus Berlin Buch: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source
🇩🇪Researchcharite.de

Campus Benjamin Franklin: Charité – Universitätsmedizin Berlin

Charité (Full Press Center)Original source
🇺🇸Industrycencora.com

Heather Zenk - Supply Chain innovation | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

Driving successful pharma supply chain solutions | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

Thoughtspot 2025 | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

FDA 12-digit NDC format | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

Matt Sample on DSCSA Developments 2026 | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

US distribution of Kite CAR T-cell therapies | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

Cencora leaders share insights at Asembia AXS26 | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇺🇸Industrycencora.com

Cencora Launches Next-Generation Nucleus Solution | Cencora

Cencora (formerly AmerisourceBergen)Original source
🇫🇷Industrycellectis.com

Press | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Press | Cellectis

CellectisOriginal source
🇫🇷Industrycellectis.com

13 Apr 2026 04:30 E.S.T. Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform Read more

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis to Report First Quarter Financial Results on May 11, 2026 | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

12 May 2026 09:30 E.S.T. Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress Read more

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Reports Financial Results for the First Quarter 2026 | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting | Cellectis

Cellectis (Global)Original source
🇫🇷Industrycellectis.com

Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 | Cellectis

Cellectis (Global)Original source
🇳🇱CDMOcastoredc.com

HealthVerity and Castor launch partnership to seamlessly incorporate real-world data throughout the clinical trial lifecycle

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor adds nearly 10 commercial Phase II/III eCOA studies in H2 2025

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Supports LLS in Study to Improve Blood Testing

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Launches "Castor for Impact Program" to Advance Health Equity in Clinical Research

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Joins C-Path eCOA Consortium, Surpassing 300 Industry Study Milestone

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Introduces Castor CoPilot, A Novel AI Solution for Clinical Trials

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Catalyst: Launching Self-Driving Clinical Trials with Google Cloud AI

Castor EDCOriginal source
🇳🇱CDMOcastoredc.com

Castor Bolsters Remote Study Engagement with Streamlined Participant Workflow

Castor EDCOriginal source
🌍Researchcaprisa.org

Get to know our Scientists

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

NIHR-funded studies

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

HIV Prevention and Epidemiology

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

EDCTP-funded studies

CAPRISA ResearchOriginal source
🌍Researchcaprisa.org

CAPRISA Centres of Excellence

CAPRISA ResearchOriginal source
🇨🇦Regulatorycanada.ca

Transport and infrastructure

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Policing, justice and emergencies

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Manage life events

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Immigration and citizenship

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Environment and natural resources

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

National security and defence

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Culture, history and sport

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Phenytoin sodium capsules and phenytoin chewable tablets in short supply: Notice

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Glucagon for injection supply in Canada: Notice

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Post-notice of compliance changes

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

International Council for Harmonisation (ICH)

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Policy statement: Reconsideration of decisions for priority review status and advance consideration of Notice of Compliance with conditions (NOC/c)

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Final notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, or human cell-conditioned media

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Drug products

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Updated: Guidance on nitrosamine impurities in medications

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

New website for health product shortages

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Drugs and health products

Health CanadaOriginal source
🇨🇦Regulatorycanada.ca

Closed consultation on the proposed phased implementation of the incorporated by reference list for the Ministerial Reliance Order

Health CanadaOriginal source